{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:38:02Z","timestamp":1793050682547,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tenosynovial giant cell tumor (TSGCT) is a benign fibrohistiocytic tumor that affects the synovium of joints, bursa, and tendon sheaths and is categorized into localized TSGCT (LTSGCT) and diffuse TSGCT (DTSGCT). LTSGCT and DTSGCT are characterized by recurrent fusions involving the colony-stimulating factor 1 (<jats:italic>CSF1<\/jats:italic>) gene and its translocation partner collagen type VI alpha 3 chain. The fusion gene induces intratumoral overexpression of <jats:italic>CSF1<\/jats:italic> mRNA and CSF1 protein. CSF1 expression is a characteristic finding of TSGCT and detection of <jats:italic>CSF1<\/jats:italic> mRNA and CSF1 protein may be useful for the pathological diagnosis. Although there have been no effective anti-CSF1 antibodies to date, in situ hybridization (ISH) for <jats:italic>CSF1<\/jats:italic> mRNA has been performed to detect <jats:italic>CSF1<\/jats:italic> expression in TSGCT. We performed CSF1 immunohistochemistry (IHC) using anti-CSF1 antibody (clone 2D10) in cases of TSGCT, giant cell-rich tumor (GCRT), and GCRT-like lesion and verified its utility for the pathological diagnosis of TSGCT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed CSF1 IHC in 110 cases including 44 LTSGCTs, 20 DTSGCTs, 1 malignant TSGCT (MTSGCT), 10 giant cell tumors of bone, 2 giant cell reparative granulomas, 3 aneurysmal bone cysts, 10 undifferentiated pleomorphic sarcomas, 10 leiomyosarcomas, and 10 myxofibrosarcomas. We performed fluorescence ISH (FISH) for <jats:italic>CSF1<\/jats:italic> rearrangement to confirm CSF1 expression on IHC in TSGCTs. We considered the specimens to have <jats:italic>CSF1<\/jats:italic> rearrangement if a split signal was observed in greater than 2% of the tumor cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 50 of 65 TSGCT cases, including 35 of the 44 LTSGCTs and 15 of the 20 DTSGCTs, showed distinct scattered expression of CSF1 in the majority of mononuclear tumor cells. MTSGCT showed no CSF1 expression. Non-TSGCT cases were negative for CSF1. FISH revealed <jats:italic>CSF1<\/jats:italic> rearrangement in 6 of 7 CSF1-positive cases on IHC. On the other hand, FISH detected no <jats:italic>CSF1<\/jats:italic> rearrangement in all CSF1-negative cases on IHC. Thus, the results of IHC corresponded to those of FISH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We revealed characteristic CSF1 expression on IHC in cases of TSGCT, whereas the cases of non-TSGCT exhibited no CSF1 expression. CSF1 IHC may be useful for differentiating TSGCTs from histologically mimicking GCRTs and GCRT-like lesions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01266-9","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T06:02:38Z","timestamp":1667282558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue"],"prefix":"10.1186","volume":"17","author":[{"given":"Shintaro","family":"Sugita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Takenami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Murahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Emori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"1266_CR1","first-page":"133","volume-title":"Tenosynovial giant cell tumor, WHO classification of tumours of soft tissue and bone","author":"M von de Rijn","year":"2020","unstructured":"de Saint Aubain Somerhausen N. von de Rijn M. In: Antonescu CR, Blay JV, Bovee JVMG et al, editors. Tenosynovial giant cell tumor, WHO classification of tumours of soft tissue and bone. 5th ed. Lyon: IARC press; 2020. pp.\u00a0133\u20136.","edition":"5"},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1186\/s12885-018-5188-6","volume":"18","author":"R Nakayama","year":"2018","unstructured":"Nakayama R, Jagannathan JP, Ramaiya N, Ferrone ML, Raut CP, Ready JE, et al. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy. BMC Cancer. 2018;18:1296.","journal-title":"BMC Cancer"},{"key":"1266_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41379-018-0129-0","volume":"32","author":"A Al-Ibraheemi","year":"2019","unstructured":"Al-Ibraheemi A, Ahrens WA, Fritchie K, Dong J, Oliveira AM, Balzer B, et al. Malignant Tenosynovial Giant Cell Tumor: The True \u201cSynovial Sarcoma?\u201c A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes. Mod Pathol. 2019;32:242\u201351.","journal-title":"Mod Pathol"},{"key":"1266_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1073\/pnas.0507321103","volume":"103","author":"RB West","year":"2006","unstructured":"West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006;103:690\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1266_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","volume":"31","author":"JS Cupp","year":"2007","unstructured":"Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O\u2019Connell JX, Huntsman D, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitis. Am J Surg Pathol. 2007;31:970\u20136.","journal-title":"Am J Surg Pathol"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/his.13744","volume":"74","author":"MJL Mastboom","year":"2019","unstructured":"Mastboom MJL, Hoek DM, Bov\u00e9e JVMG, van de Sande MAJ, Szuhai K. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Histopathology. 2019;74:332\u201340.","journal-title":"Histopathology"},{"key":"1266_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13000-016-0486-2","volume":"11","author":"S Sugita","year":"2016","unstructured":"Sugita S, Asanuma H, Hasegawa T. Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma. Diagn Pathol. 2016;11:37.","journal-title":"Diagn Pathol"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jcb.240380305","volume":"38","author":"CJ Sherr","year":"1988","unstructured":"Sherr CJ, Roussel MF, Rettenmier CW. Colony-stimulating factor-1 receptor (c-fms). J Cell Biochem. 1988;38:179\u201387.","journal-title":"J Cell Biochem"},{"key":"1266_CR9","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","volume":"20","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, et al. CSF1\/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. Mol Cancer Ther. 2021;20:1388\u201399.","journal-title":"Mol Cancer Ther"},{"key":"1266_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2021.05.010","volume":"115","author":"JJ Thangaiah","year":"2021","unstructured":"Thangaiah JJ, Koepplin JW, Folpe AL. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors. Hum Pathol. 2021;115:1\u20139.","journal-title":"Hum Pathol"},{"key":"1266_CR11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.ajpath.2011.06.021","volume":"179","author":"I Espinosa","year":"2011","unstructured":"Espinosa I, Edris B, Lee CH, Cheng HW, Gilks CB, Wang Y, et al. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. Am J Pathol. 2011;179:2100\u20137.","journal-title":"Am J Pathol"},{"key":"1266_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/cancers12010100","volume":"12","author":"T Vougiouklakis","year":"2019","unstructured":"Vougiouklakis T, Shen G, Feng X, Hoda ST, Jour G. Molecular Profiling of Atypical Tenosynovial Giant Cell Tumors Reveals Novel Non-CSF1 Fusions. Cancers (Basel). 2019;12:100.","journal-title":"Cancers (Basel)"},{"key":"1266_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41379-021-00789-8","volume":"34","author":"A Agaimy","year":"2021","unstructured":"Agaimy A, Michal M, Stoehr R, Ferrazzi F, Fabian P, Michal M, et al. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors. Mod Pathol. 2021;34:1507\u201320.","journal-title":"Mod Pathol"},{"key":"1266_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/pin.12562","volume":"67","author":"S Sugita","year":"2017","unstructured":"Sugita S, Aoyama T, Ito Y, Asanuma H, Sugawara T, Segawa K, et al. Diagnostic utility of automated SureFISH (Dako Omnis) in the diagnosis of musculoskeletal translocation-related sarcomas. Pathol Int. 2017;67:510\u20133.","journal-title":"Pathol Int"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01266-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01266-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01266-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T18:04:56Z","timestamp":1667325896000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01266-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01266-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"16 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the IRB of Sapporo Medical University Hospital under permit number 342\u2009\u2212\u200933. The IRB approved an opt-out informed consent approach for the retrospective, non-interventional study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}